Boston Partners Buys 349,529 Shares of Maximus, Inc. $MMS

Boston Partners lifted its stake in Maximus, Inc. (NYSE:MMS) by 113.6% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 657,247 shares of the health services provider’s stock after acquiring an additional 349,529 shares during the period. Boston Partners owned 1.17% of Maximus worth $46,435,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd grew its holdings in Maximus by 17,533.3% during the first quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock valued at $36,000 after purchasing an additional 526 shares during the last quarter. UMB Bank n.a. lifted its stake in shares of Maximus by 37.5% in the second quarter. UMB Bank n.a. now owns 833 shares of the health services provider’s stock worth $58,000 after buying an additional 227 shares during the last quarter. Bayforest Capital Ltd bought a new stake in shares of Maximus during the 2nd quarter worth $61,000. Parkside Financial Bank & Trust grew its stake in Maximus by 21.7% in the 2nd quarter. Parkside Financial Bank & Trust now owns 879 shares of the health services provider’s stock valued at $62,000 after buying an additional 157 shares during the last quarter. Finally, GAMMA Investing LLC grew its stake in Maximus by 60.4% in the 2nd quarter. GAMMA Investing LLC now owns 1,174 shares of the health services provider’s stock valued at $82,000 after buying an additional 442 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Zacks Research lowered shares of Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 27th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Maximus in a research note on Wednesday. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $90.00.

Insiders Place Their Bets

In other Maximus news, insider Michelle F. Link sold 1,610 shares of Maximus stock in a transaction on Wednesday, October 1st. The shares were sold at an average price of $90.86, for a total transaction of $146,284.60. Following the sale, the insider owned 13,508 shares in the company, valued at $1,227,336.88. The trade was a 10.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 1.60% of the stock is owned by corporate insiders.

Maximus Stock Down 0.4%

MMS stock opened at $86.30 on Friday. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $92.50. The company has a quick ratio of 2.27, a current ratio of 2.27 and a debt-to-equity ratio of 0.91. The company has a market cap of $4.70 billion, a PE ratio of 15.89 and a beta of 0.57. The business’s 50-day simple moving average is $85.73 and its 200 day simple moving average is $79.91.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, November 20th. The health services provider reported $1.62 EPS for the quarter, missing the consensus estimate of $1.63 by ($0.01). Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm had revenue of $1.32 billion during the quarter, compared to analyst estimates of $1.34 billion. During the same period last year, the company earned $1.46 EPS. The company’s revenue was up .2% on a year-over-year basis. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. On average, research analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, December 1st. Investors of record on Friday, November 14th will be given a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.4%. The ex-dividend date of this dividend is Friday, November 14th. Maximus’s dividend payout ratio (DPR) is 21.58%.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.